Etbmed 150 mg Tablet 30's belongs to the group of medicine called ‘anti-cancer’ primarily used for lung and pancreatic cancer treatment. Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs. These abnormal cells do not carry out normal lung cell functions and do not develop into healthy lung tissue. In this disease, cells of the lung grow uncontrollably, and if not detected at an early stage may spread to other body parts, including the brain. Pancreatic cancer is an uncontrolled cancerous growth in the pancreas, usually in the cells that produce insulin.

Etbmed 150 mg Tablet 30's contains 'Erlotinib' that belongs to the group of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it prevents the spread of cancerous cells.

Take Etbmed 150 mg Tablet 30's as prescribed by your doctor. You are suggested to take Etbmed 150 mg Tablet 30's as long as your doctor has prescribed it after checking your medical condition.  In some cases, you may experience certain common side-effects such as abdominal pain, bone pain, breathlessness, constipation, cough, diarrhea, edema (swelling), fatigue, fever, infection, muscle pain, nausea, rash, stomatitis (inflammation of the mouth), vomiting, weight loss abnormal blood tests for the liver function. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.

To treat your condition effectually, continue taking Etbmed 150 mg Tablet 30's for as long as your doctor has prescribed. Do not take Etbmed 150 mg Tablet 30's if you are pregnant or planning for pregnancy and breastfeeding as Etbmed 150 mg Tablet 30's causes serious congenital disabilities. Older adults are more sensitive to medicine so that they may adjust the dosage according to the condition. While taking Etbmed 150 mg Tablet 30's, you might become more sensitive to sunlight, so it is important to protect your skin with a high sun protection factor (SPF). Regular blood tests are required to monitor liver function and blood cells in the blood while taking Etbmed 150 mg Tablet 30's. Avoid consuming alcohol along with Etbmed 150 mg Tablet 30's as it could lead to increased dizziness.

Etbmed 150 mg Tablet 30's is prescribed to the patients dealing with nonsmall cell lung cancer and pancreatic cancer. Cancer of this type tends to spread quickly in other parts of the body. Etbmed 150 mg Tablet 30's travel through the bloodstream and effectively destroy cancerous cells of the lung, pancreas, and other body parts. Etbmed 150 mg Tablet 30's contains Erlotinib is a 'tyrosine kinase inhibitor (TKI)' that stops the uncontrolled growth and spread of cancerous cells. It acts by blocking the abnormal protein's action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so Etbmed 150 mg Tablet 30's targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Etbmed 150 mg Tablet 30's stops the production, spread, and growth of cancerous cells in the body. 

Do not take Etbmed 150 mg Tablet 30's if you are allergic to Etbmed 150 mg Tablet 30's or any of its ingredients. While taking Etbmed 150 mg Tablet 30's, you might become more sensitive to sunlight, so it is important to protect your skin with a high sun protection factor (SPF) while going out as it can lead to a skin rash if you are not using a strong SPF. Etbmed 150 mg Tablet 30's can cause leg swelling and water retention or fluid overload (edema), so if you have unexpected rapid weight gain, please consult your doctor. Do not take Etbmed 150 mg Tablet 30's if you are pregnant or planning to get pregnant and breastfeeding as it could harm the unborn baby. Use effective birth control measures while taking this medication and for at least 1 month after your last dose. Etbmed 150 mg Tablet 30's is not recommended for children and adolescents. You are advised to stop smoking while taking Etbmed 150 mg Tablet 30's as smoking could decrease this medication's effect. Etbmed 150 mg Tablet 30's may make you more susceptible to infections, consult your doctor if you develop any signs of infections, fever, sore throat, breathlessness, jaundice, unexplained bleeding, or bruising.  Etbmed 150 mg Tablet 30's may cause blurry vision and dizziness, so do not drive or operate any machinery which requires concentration. Before undergoing any surgery, it is advised to tell the medical professional who performs the procedure about all the medicines you are taking. 

• ​​​​​​Regular blood test is required to monitor liver function and blood cells in blood while taking Etbmed 150 mg Tablet 30's.
• While taking Etbmed 150 mg Tablet 30's, you might become more sensitive to sunlight, so it is important to protect your skin with a high sun protection factor (SPF) while going out as it can lead to a skin rash if you are not using a strong SPF.
• Always take it with food and a full glass of water to prevent nausea.
• Etbmed 150 mg Tablet 30's can cause swelling and water retention, so if you have unexpected rapid weight gain, please consult your doctor. 
• Do not have immunizations with live vaccines (for mumps, rubella, measles and BCG, yellow fever and shingles or pox chicken) while you’re having treatment and for up to 12 months afterward. 
• Contact your doctor immediately if you experience any infection signs, including a temperature above 37.5 C or below 36 C.